Mr Daniel Gaya

  • Honorary Professor (School of Medicine, Dentistry & Nursing)

email: Daniel.Gaya@glasgow.ac.uk

Gastroenterology Unit, Glasgow Royal Infirmary, Glasgow, Uk

Import to contacts

Publications

List by: Type | Date

Jump to: 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2014 | 2013 | 2011 | 2009 | 2008 | 2007 | 2005
Number of items: 36.

2023

Jatkowska, A. et al. (2023) Development and validation of the Glasgow Exclusive Enteral Nutrition Index of Compliance. Journal of Crohn's and Colitis, 17(9), pp. 1426-1435. (doi: 10.1093/ecco-jcc/jjad063) (PMID:37004165) (PMCID:PMC10588781)

2022

Gerasimidis, K. et al. (2022) The effects of commonly consumed dietary fibres on the gut microbiome and its fibre fermentative capacity in adults with inflammatory bowel disease in remission. Nutrients, 14(5), 1053. (doi: 10.3390/nu14051053) (PMID:35268028) (PMCID:PMC8912623)

2021

Wright, P. B. et al. (2021) The mannose receptor (CD206) identifies a population of colonic macrophages in health and inflammatory bowel disease. Scientific Reports, 11, 19616. (doi: 10.1038/s41598-021-98611-7) (PMID:34608184) (PMCID:PMC8490356)

Hanna, C. R. et al. (2021) Durvalumab (MEDI 4736) in combination with extended neoadjuvant regimens in rectal cancer: a study protocol of a randomised phase II trial (PRIME-RT). Radiation Oncology, 16, 163. (doi: 10.1186/s13014-021-01888-1) (PMID:34446053)

Steell, L. , Gray, S. R. , Russell, R. K., MacDonald, J. , Seenan, J. P. , Wong, S. C. and Gaya, D. R. (2021) Pathogenesis of musculoskeletal deficits in children and adults with inflammatory bowel disease. Nutrients, 13(8), 2899. (doi: 10.3390/nu13082899)

MacMaster, M. J., Damianopoulou, S., Thomson, C., Talwar, D., Stefanowicz, F., Catchpole, A., Gerasimidis, K. and Gaya, D. R. (2021) A prospective analysis of micronutrient status in quiescent inflammatory bowel disease. Clinical Nutrition, 40(1), pp. 327-331. (doi: 10.1016/j.clnu.2020.05.010) (PMID:32517876)

2020

Steell, L. et al. (2020) Muscle deficits with normal bone microarchitecture and geometry in young adults with well controlled childhood onset Crohn’s disease. European Journal of Gastroenterology and Hepatology, 32(12), pp. 1497-1506. (doi: 10.1097/MEG.0000000000001838) (PMID:32675776)

Kennedy, N. A. et al. (2020) British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic. Gut, 69(6), pp. 984-990. (doi: 10.1136/gutjnl-2020-321244) (PMID:32303607) (PMCID:PMC7211081)

Logan, M. et al. (2020) Analysis of 61 exclusive enteral nutrition formulas used in management of active Crohn's disease - new insights into dietary disease triggers. Alimentary Pharmacology and Therapeutics, 51(10), pp. 935-947. (doi: 10.1111/apt.15695) (PMID:32249975)

2019

Lamb, C. A. et al. (2019) British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut, 68(Suppl3), s1-s106. (doi: 10.1136/gutjnl-2019-318484) (PMID:31562236) (PMCID:PMC6872448)

Quraishi, M. N. N. et al. (2019) STOP-Colitis pilot trial protocol: a prospective, open-label, randomised pilot study to assess two possible routes of faecal microbiota transplant delivery in patients with ulcerative colitis. BMJ Open, 9(11), e030659. (doi: 10.1136/bmjopen-2019-030659) (PMID:31719078) (PMCID:PMC6858155)

Gerasimidis, K. , Svolos, V., Nichols, B., Papadopoulou, R., Quince, C., Ijaz, U. Z. , Milling, S. , Gaya, D. R., Russell, R. K. and Hansen, R. (2019) Reply. Gastroenterology, 157(4), pp. 1161-1162. (doi: 10.1053/j.gastro.2019.08.015) (PMID:31408620)

Wang, C., Baer, H. M., Gaya, D. R., Nibbs, R. J.B. and Milling, S. (2019) Can molecular stratification improve the treatment of inflammatory bowel disease? Pharmacological Research, 148, 104442. (doi: 10.1016/j.phrs.2019.104442) (PMID:31491469) (PMCID:PMC6902263)

Svolos, V. et al. (2019) Treatment of active Crohn’s disease with an ordinary food-based diet that replicates exclusive enteral nutrition. Gastroenterology, 156(5), 1354-1367.e6. (doi: 10.1053/j.gastro.2018.12.002) (PMID:30550821)

Lomer, M. C.E., Cahill, O., Baschali, A., Partha Sarathy, P., Sarantidou, M., Mantzaris, G. J., Gaya, D., Katsanos, K., Christodoulou, D. and Gerasimidis, K. (2019) A multicentre study of nutrition risk assessment in adult patients with inflammatory bowel disease attending outpatient clinics. Annals of Nutrition and Metabolism, 74(1), pp. 18-23. (doi: 10.1159/000495214) (PMID:30485836)

2018

Barroso, T., Conway, F., Emel, S., McMillan, D. , Young, D., Karteszi, H., Gaya, D. R. and Gerasimidis, K. (2018) Patients with inflammatory bowel disease have higher abdominal adiposity and less skeletal mass than healthy controls. Annals of Gastroenterology, 31(5), pp. 566-571. (doi: 10.20524/aog.2018.0280) (PMID:30174393) (PMCID:PMC6102468)

Mason, A., Gerasimidis, K. , Iljuhhina, J., Laird, S., Munro, J., Gaya, D. R., Russell, R. K. and Ahmed, S. F. (2018) Long-term skeletal disproportion in childhood-onset Crohn’s disease. Hormone Research in Paediatrics, 89(2), pp. 132-135. (doi: 10.1159/000485185)

2017

Brooks, A. J. et al. (2017) UK guideline on transition of adolescent and young persons with chronic digestive diseases from paediatric to adult care. Gut, 66(6), pp. 988-1000. (doi: 10.1136/gutjnl-2016-313000) (PMID:28228488)

Ijaz, U. Z. et al. (2017) The distinct features of microbial 'dysbiosis' of Crohn's disease do not occur to the same extent in their unaffected, genetically linked kindred. PLoS ONE, 12(2), e0172605. (doi: 10.1371/journal.pone.0172605) (PMID:28222161) (PMCID:PMC5319678)

Svolos, V. et al. (2017) Dietary treatment of Crohn’s disease: perceptions of families with children treated by exclusive enteral nutrition, a questionnaire survey. BMC Gastroenterology, 17, 14. (doi: 10.1186/s12876-016-0564-7) (PMID:28103809) (PMCID:PMC5247812)

Siebert, S. , Porter, D., Paterson, C., Hampson, R., Gaya, D., Latosinska, A., Mischak, H., Schanstra, J., Mullen, W. and McInnes, I. (2017) Urinary proteomics can define distinct diagnostic inflammatory arthritis subgroups. Scientific Reports, 7, 40473. (doi: 10.1038/srep40473) (PMID:28091549) (PMCID:PMC5320079)

2016

Svolos, V., Hansen, R., Hughes, K., Ijaz, U.Z. , Quince, C., Gaya, D., Russell, R. and Gerasimidis, K. (2016) The Impact of ‘Crohn’s Disease-TReatment-with-EATing’ Diet (CD-TREAT Diet) and Exclusive Enteral Nutrition on Healthy Gut Bacteria Metabolism. 11th Congress of the European Crohn's and Colitis Organisation, Amsterdam, The Netherlands, 16-19 March 2016. S14-S15. (doi: 10.1093/ecco-jcc/jjw019.017)

2014

Kennedy, N.A. et al. (2014) Thiopurine withdrawal during sustained clinical remission in inflammatory bowel disease: relapse and recapture rates, with predictive factors in 237 patients. Alimentary Pharmacology and Therapeutics, 40(11-12), pp. 1313-1323. (doi: 10.1111/apt.12980)

Stanley, A. J. et al. (2014) Multicentre randomised controlled study comparing carvedilol with variceal band ligation in the prevention of variceal rebleeding. Journal of Hepatology, 61(5), pp. 1014-1019. (doi: 10.1016/j.jhep.2014.06.015) (PMID:24953021)

Heap, G. A. et al. (2014) HLA-DQA1–HLA-DRB1 variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressants. Nature Genetics, 46(10), pp. 1131-1134. (doi: 10.1038/ng.3093) (PMID:25217962)

Naismith, G. D., Smith, L. A., Barry, S. J.E. , Munro, J. I., Laird, S., Rankin, K., Morris, A. J., Winter, J. W. and Gaya, D. R. (2014) A prospective evaluation of the predictive value of faecal calprotectin in quiescent Crohn’s disease. Journal of Crohn's and Colitis, 8(9), pp. 1022-1029. (doi: 10.1016/j.crohns.2014.01.029)

Mabvuure, N. T., Maclean, L., Oien, K. and Gaya, D. (2014) Cytomegalovirus pouchitis in a patient with Crohn's disease. BMJ Case Reports, 2014(jul17), bcr2014205374-bcr2014205374. (doi: 10.1136/bcr-2014-205374) (PMID:25035450)

Gaya, D.R. (2014) Delivering optimal care for inflammatory bowel disease patients in Scotland in 2014. Scottish Medical Journal, 59(2), pp. 130-135. (doi: 10.1177/0036933014531540) (PMID:24728818)

Reed, E. A. et al. (2014) Is the Glasgow Blatchford score useful in the risk assessment of patients presenting with variceal haemorrhage? European Journal of Gastroenterology and Hepatology, 26(4), pp. 432-437. (doi: 10.1097/MEG.0000000000000051) (PMID:24535596)

2013

Naismith, G.D., Smith, L.A., Barry, S.J.E. , Munro, J.I., Laird, S., Rankin, K., Morris, A.J., Winter, J.W. and Gaya, D. (2013) A prospective single centre evaluation of the intra-individual variability of faecal calprotectin in quiescent Crohns disease. Alimentary Pharmacology and Therapeutics, 37(6), pp. 613-621. (doi: 10.1111/apt.12221)

2011

Stanley, A.J. et al. (2011) Multicentre comparison of the Glasgow Blatchford and Rockall scores in the prediction of clinical end-points after upper gastrointestinal haemorrhage. Alimentary Pharmacology and Therapeutics, 34(4), pp. 470-475. (doi: 10.1111/j.1365-2036.2011.04747.x) (PMID:21707681)

Rajoriya, N., Forrest, E.H., Gray, J., Stuart, R.C., Carter, R.C., Mackay, C.J., Gaya, D.R., Morris, A.J. and Stanley, A.J. (2011) Long-term follow-up of endoscopic histoacryl glue injection for the management of gastric variceal bleeding. QJM: An International Journal of Medicine, 104(1), pp. 41-47. (doi: 10.1093/qjmed/hcq161) (PMID:20871126)

2009

Stanley, A.J. et al. (2009) Outpatient management of patients with low-risk upper-gastrointestinal haemorrhage: multicentre validation and prospective evaluation. Lancet, 373(9657), pp. 42-47. (doi: 10.1016/S0140-6736(08)61769-9) (PMID:19091393)

2008

Gaya, D. R., Stuart, R. C., Going, J. J. and Stanley, A. J. (2008) Hereditary diffuse gastric cancer associated with E-cadherin mutation: penetrance after all. European Journal of Gastroenterology and Hepatology, 20(12), pp. 1205-1213. (doi: 10.1097/MEG.0b013e328303df31)

2007

Gaya, D. R., Lyon, T. D. B., Clarke, J., Jamdar, S., Inverarity, D., Forrest, E. H., Morris, A. J. and Stanley, A. J. (2007) Bedside leucocyte esterase reagent strips with spectrophotometric analysis to rapidly exclude spontaneous bacterial peritonitis: a pilot study. European Journal of Gastroenterology and Hepatology, 19(4), pp. 289-295. (doi: 10.1097/MEG.0b013e328013e991) (PMID:17353692) (PMCID:17353692)

2005

Gaya, D.R., Lyon, T.D.B., Duncan, A., Neilly, J.B., Han, S., Howell, J., Liddell, C., Stanley, A.J., Morris, A.J. and Mackenzie, J.F. (2005) Faecal calprotectin in the assessment of Crohn's disease activity. QJM: An International Journal of Medicine, 98(6), pp. 435-441. (doi: 10.1093/qjmed/hci069) (PMID:15879440)

This list was generated on Mon Apr 22 02:34:12 2024 BST.
Number of items: 36.

Articles

Jatkowska, A. et al. (2023) Development and validation of the Glasgow Exclusive Enteral Nutrition Index of Compliance. Journal of Crohn's and Colitis, 17(9), pp. 1426-1435. (doi: 10.1093/ecco-jcc/jjad063) (PMID:37004165) (PMCID:PMC10588781)

Gerasimidis, K. et al. (2022) The effects of commonly consumed dietary fibres on the gut microbiome and its fibre fermentative capacity in adults with inflammatory bowel disease in remission. Nutrients, 14(5), 1053. (doi: 10.3390/nu14051053) (PMID:35268028) (PMCID:PMC8912623)

Wright, P. B. et al. (2021) The mannose receptor (CD206) identifies a population of colonic macrophages in health and inflammatory bowel disease. Scientific Reports, 11, 19616. (doi: 10.1038/s41598-021-98611-7) (PMID:34608184) (PMCID:PMC8490356)

Hanna, C. R. et al. (2021) Durvalumab (MEDI 4736) in combination with extended neoadjuvant regimens in rectal cancer: a study protocol of a randomised phase II trial (PRIME-RT). Radiation Oncology, 16, 163. (doi: 10.1186/s13014-021-01888-1) (PMID:34446053)

Steell, L. , Gray, S. R. , Russell, R. K., MacDonald, J. , Seenan, J. P. , Wong, S. C. and Gaya, D. R. (2021) Pathogenesis of musculoskeletal deficits in children and adults with inflammatory bowel disease. Nutrients, 13(8), 2899. (doi: 10.3390/nu13082899)

MacMaster, M. J., Damianopoulou, S., Thomson, C., Talwar, D., Stefanowicz, F., Catchpole, A., Gerasimidis, K. and Gaya, D. R. (2021) A prospective analysis of micronutrient status in quiescent inflammatory bowel disease. Clinical Nutrition, 40(1), pp. 327-331. (doi: 10.1016/j.clnu.2020.05.010) (PMID:32517876)

Steell, L. et al. (2020) Muscle deficits with normal bone microarchitecture and geometry in young adults with well controlled childhood onset Crohn’s disease. European Journal of Gastroenterology and Hepatology, 32(12), pp. 1497-1506. (doi: 10.1097/MEG.0000000000001838) (PMID:32675776)

Kennedy, N. A. et al. (2020) British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic. Gut, 69(6), pp. 984-990. (doi: 10.1136/gutjnl-2020-321244) (PMID:32303607) (PMCID:PMC7211081)

Logan, M. et al. (2020) Analysis of 61 exclusive enteral nutrition formulas used in management of active Crohn's disease - new insights into dietary disease triggers. Alimentary Pharmacology and Therapeutics, 51(10), pp. 935-947. (doi: 10.1111/apt.15695) (PMID:32249975)

Lamb, C. A. et al. (2019) British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut, 68(Suppl3), s1-s106. (doi: 10.1136/gutjnl-2019-318484) (PMID:31562236) (PMCID:PMC6872448)

Quraishi, M. N. N. et al. (2019) STOP-Colitis pilot trial protocol: a prospective, open-label, randomised pilot study to assess two possible routes of faecal microbiota transplant delivery in patients with ulcerative colitis. BMJ Open, 9(11), e030659. (doi: 10.1136/bmjopen-2019-030659) (PMID:31719078) (PMCID:PMC6858155)

Gerasimidis, K. , Svolos, V., Nichols, B., Papadopoulou, R., Quince, C., Ijaz, U. Z. , Milling, S. , Gaya, D. R., Russell, R. K. and Hansen, R. (2019) Reply. Gastroenterology, 157(4), pp. 1161-1162. (doi: 10.1053/j.gastro.2019.08.015) (PMID:31408620)

Wang, C., Baer, H. M., Gaya, D. R., Nibbs, R. J.B. and Milling, S. (2019) Can molecular stratification improve the treatment of inflammatory bowel disease? Pharmacological Research, 148, 104442. (doi: 10.1016/j.phrs.2019.104442) (PMID:31491469) (PMCID:PMC6902263)

Svolos, V. et al. (2019) Treatment of active Crohn’s disease with an ordinary food-based diet that replicates exclusive enteral nutrition. Gastroenterology, 156(5), 1354-1367.e6. (doi: 10.1053/j.gastro.2018.12.002) (PMID:30550821)

Lomer, M. C.E., Cahill, O., Baschali, A., Partha Sarathy, P., Sarantidou, M., Mantzaris, G. J., Gaya, D., Katsanos, K., Christodoulou, D. and Gerasimidis, K. (2019) A multicentre study of nutrition risk assessment in adult patients with inflammatory bowel disease attending outpatient clinics. Annals of Nutrition and Metabolism, 74(1), pp. 18-23. (doi: 10.1159/000495214) (PMID:30485836)

Barroso, T., Conway, F., Emel, S., McMillan, D. , Young, D., Karteszi, H., Gaya, D. R. and Gerasimidis, K. (2018) Patients with inflammatory bowel disease have higher abdominal adiposity and less skeletal mass than healthy controls. Annals of Gastroenterology, 31(5), pp. 566-571. (doi: 10.20524/aog.2018.0280) (PMID:30174393) (PMCID:PMC6102468)

Mason, A., Gerasimidis, K. , Iljuhhina, J., Laird, S., Munro, J., Gaya, D. R., Russell, R. K. and Ahmed, S. F. (2018) Long-term skeletal disproportion in childhood-onset Crohn’s disease. Hormone Research in Paediatrics, 89(2), pp. 132-135. (doi: 10.1159/000485185)

Brooks, A. J. et al. (2017) UK guideline on transition of adolescent and young persons with chronic digestive diseases from paediatric to adult care. Gut, 66(6), pp. 988-1000. (doi: 10.1136/gutjnl-2016-313000) (PMID:28228488)

Ijaz, U. Z. et al. (2017) The distinct features of microbial 'dysbiosis' of Crohn's disease do not occur to the same extent in their unaffected, genetically linked kindred. PLoS ONE, 12(2), e0172605. (doi: 10.1371/journal.pone.0172605) (PMID:28222161) (PMCID:PMC5319678)

Svolos, V. et al. (2017) Dietary treatment of Crohn’s disease: perceptions of families with children treated by exclusive enteral nutrition, a questionnaire survey. BMC Gastroenterology, 17, 14. (doi: 10.1186/s12876-016-0564-7) (PMID:28103809) (PMCID:PMC5247812)

Siebert, S. , Porter, D., Paterson, C., Hampson, R., Gaya, D., Latosinska, A., Mischak, H., Schanstra, J., Mullen, W. and McInnes, I. (2017) Urinary proteomics can define distinct diagnostic inflammatory arthritis subgroups. Scientific Reports, 7, 40473. (doi: 10.1038/srep40473) (PMID:28091549) (PMCID:PMC5320079)

Kennedy, N.A. et al. (2014) Thiopurine withdrawal during sustained clinical remission in inflammatory bowel disease: relapse and recapture rates, with predictive factors in 237 patients. Alimentary Pharmacology and Therapeutics, 40(11-12), pp. 1313-1323. (doi: 10.1111/apt.12980)

Stanley, A. J. et al. (2014) Multicentre randomised controlled study comparing carvedilol with variceal band ligation in the prevention of variceal rebleeding. Journal of Hepatology, 61(5), pp. 1014-1019. (doi: 10.1016/j.jhep.2014.06.015) (PMID:24953021)

Heap, G. A. et al. (2014) HLA-DQA1–HLA-DRB1 variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressants. Nature Genetics, 46(10), pp. 1131-1134. (doi: 10.1038/ng.3093) (PMID:25217962)

Naismith, G. D., Smith, L. A., Barry, S. J.E. , Munro, J. I., Laird, S., Rankin, K., Morris, A. J., Winter, J. W. and Gaya, D. R. (2014) A prospective evaluation of the predictive value of faecal calprotectin in quiescent Crohn’s disease. Journal of Crohn's and Colitis, 8(9), pp. 1022-1029. (doi: 10.1016/j.crohns.2014.01.029)

Mabvuure, N. T., Maclean, L., Oien, K. and Gaya, D. (2014) Cytomegalovirus pouchitis in a patient with Crohn's disease. BMJ Case Reports, 2014(jul17), bcr2014205374-bcr2014205374. (doi: 10.1136/bcr-2014-205374) (PMID:25035450)

Gaya, D.R. (2014) Delivering optimal care for inflammatory bowel disease patients in Scotland in 2014. Scottish Medical Journal, 59(2), pp. 130-135. (doi: 10.1177/0036933014531540) (PMID:24728818)

Reed, E. A. et al. (2014) Is the Glasgow Blatchford score useful in the risk assessment of patients presenting with variceal haemorrhage? European Journal of Gastroenterology and Hepatology, 26(4), pp. 432-437. (doi: 10.1097/MEG.0000000000000051) (PMID:24535596)

Naismith, G.D., Smith, L.A., Barry, S.J.E. , Munro, J.I., Laird, S., Rankin, K., Morris, A.J., Winter, J.W. and Gaya, D. (2013) A prospective single centre evaluation of the intra-individual variability of faecal calprotectin in quiescent Crohns disease. Alimentary Pharmacology and Therapeutics, 37(6), pp. 613-621. (doi: 10.1111/apt.12221)

Stanley, A.J. et al. (2011) Multicentre comparison of the Glasgow Blatchford and Rockall scores in the prediction of clinical end-points after upper gastrointestinal haemorrhage. Alimentary Pharmacology and Therapeutics, 34(4), pp. 470-475. (doi: 10.1111/j.1365-2036.2011.04747.x) (PMID:21707681)

Rajoriya, N., Forrest, E.H., Gray, J., Stuart, R.C., Carter, R.C., Mackay, C.J., Gaya, D.R., Morris, A.J. and Stanley, A.J. (2011) Long-term follow-up of endoscopic histoacryl glue injection for the management of gastric variceal bleeding. QJM: An International Journal of Medicine, 104(1), pp. 41-47. (doi: 10.1093/qjmed/hcq161) (PMID:20871126)

Stanley, A.J. et al. (2009) Outpatient management of patients with low-risk upper-gastrointestinal haemorrhage: multicentre validation and prospective evaluation. Lancet, 373(9657), pp. 42-47. (doi: 10.1016/S0140-6736(08)61769-9) (PMID:19091393)

Gaya, D. R., Stuart, R. C., Going, J. J. and Stanley, A. J. (2008) Hereditary diffuse gastric cancer associated with E-cadherin mutation: penetrance after all. European Journal of Gastroenterology and Hepatology, 20(12), pp. 1205-1213. (doi: 10.1097/MEG.0b013e328303df31)

Gaya, D. R., Lyon, T. D. B., Clarke, J., Jamdar, S., Inverarity, D., Forrest, E. H., Morris, A. J. and Stanley, A. J. (2007) Bedside leucocyte esterase reagent strips with spectrophotometric analysis to rapidly exclude spontaneous bacterial peritonitis: a pilot study. European Journal of Gastroenterology and Hepatology, 19(4), pp. 289-295. (doi: 10.1097/MEG.0b013e328013e991) (PMID:17353692) (PMCID:17353692)

Gaya, D.R., Lyon, T.D.B., Duncan, A., Neilly, J.B., Han, S., Howell, J., Liddell, C., Stanley, A.J., Morris, A.J. and Mackenzie, J.F. (2005) Faecal calprotectin in the assessment of Crohn's disease activity. QJM: An International Journal of Medicine, 98(6), pp. 435-441. (doi: 10.1093/qjmed/hci069) (PMID:15879440)

Conference or Workshop Item

Svolos, V., Hansen, R., Hughes, K., Ijaz, U.Z. , Quince, C., Gaya, D., Russell, R. and Gerasimidis, K. (2016) The Impact of ‘Crohn’s Disease-TReatment-with-EATing’ Diet (CD-TREAT Diet) and Exclusive Enteral Nutrition on Healthy Gut Bacteria Metabolism. 11th Congress of the European Crohn's and Colitis Organisation, Amsterdam, The Netherlands, 16-19 March 2016. S14-S15. (doi: 10.1093/ecco-jcc/jjw019.017)

This list was generated on Mon Apr 22 02:34:12 2024 BST.